Free Newsletter
Molecular condom releases antivirals
Scientists at the University of Utah have developed a 'molecular condom' to protect women from AIDS. The smart condom is a vaginal gel that releases antiviral drugs when it comes into contact with semen. The research project is part of a widespread effort to develop microbicides to prevent the spread of HIV. There are some 16 microbicides in the developmental phase and five are being tested among African women. The researchers say the smart condom is still five years away from human testing. The scientific team would like to develop a gel that could be applied once daily or as little as once monthly.
- here's the release from the University of Utah
Related Article:
The challenges of infectious disease. Report
More stories about antiviral drugs
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
SHARE
WITH: